期刊文献+

射频消融术与立体定向放射治疗原发性小肝癌的临床效果比较

Clinical Effect Comparison of Radiofrequency Ablation and Stereotactic Radiotherapy in Treatment of Small Primary Liver Cancer
下载PDF
导出
摘要 目的探讨对原发性小肝癌采用射频消融术治疗与采用立体定向放射治疗的疗效差异。方法选择我院收治原发性小肝癌患者计95例,按照术式不同分为采用射频消融术治疗对照组(n=48)例与采用立体定向放射治疗实验组(n=47)例,对比疗效。结果两组治疗总有效率对比无显著差异,P>0.05,两组发热发生率对比无显著差异,P>0.05,实验组恶心、肝区不适、血小板降低发生率高于对照组,P<0.05,转氨酶升高发生率低于对照组,P<0.05,均未见严重不良反应。结果对原发性小肝癌患者采用射频消融术与立体定向放射治疗均具有较高的疗效,且预后情况理想,故可将立体定向放疗当做原发性小肝癌的替代手段。 Objective to investigate difference between radiofrequency ablation and stereotactic radiotherapy in treatment of small primary liver cancer.Methods choose 95 cases primary small liver cancer patients in our hospital,divide them into two groups according to different operative Methods control group(n=48)was treated with radiofrequency ablation and experimental group(n=47)with stereotactic radiotherapy.Compare curative effect of two groups.Results total effective rate showed no significant difference between two groups,P>0.05,and incidence of fever showed no significant difference between two groups,P>0.05.Incidence of nausea,discomfort in liver area and thrombocytopenia in experimental group was higher than control group,P<0.05,and incidence of transaminase elevation was lower than control group,P<0.05,and no serious adverse reactions were found.Results radiofrequency ablation and stereotactic radiotherapy both can achieve effect in treatment of primary small liver cancer,with ideal prognosis,so stereotactic radiotherapy can be an alternative to primary small liver cancer.
作者 李国强 LI Guo-qiang(Heze City Mudan People’s Hospital,Heze,Shandong 274000)
出处 《智慧健康》 2020年第9期38-39,共2页 Smart Healthcare
关键词 射频消融术 立体定向放疗 原发性肝炎 Radiofrequency ablation Stereotactic radiotherapy Primary hepatitis
  • 相关文献

参考文献10

二级参考文献82

  • 1覃怀成,孔勇.中晚期肝癌的TACE治疗进展[J].北方医药,2011,8(4):35-36.
  • 2Lau W Y, Lai E C. Hepatocellular carcinoma: current man- agement and recent advances[ J ]. Hepatobiliary Pancreat Dis Int, 2008, 7(3): 237.
  • 3Liapi E, Geschwind J F. Chemoembolization for primary and metastatic liver cancer[J]. Cancer J, 2010, 16(2) : 156.
  • 4Rice T W, Ruseh V W, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data- driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer CancerStaging Mmmals[J]. Cancer, 2010, 116(16): 3763.
  • 5Gao J, Hu Z, Wu J, et ai. Primary hepatic carcinoid tumor [J]. World J Surg Oneol, 2011; 9(5) : 151.
  • 6Zhou B, Shah H, Zhu K S, et al. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma af*er ortholopic liver transplantation [J]. J Vasc lnterv Radiol, 2010, 21(3): 333.
  • 7Zhang Y J, Liang H H, Chen M S, et al. Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial[J]. Radiology, 2007, 244(2): 599.
  • 8Siriapisith T, Siwasattayanon P, Tongdee T. Radiofrequency ablation alone versus radiofrequency ablation combined with- chemoembolization in unresectable hepatocellular carcinoma [J]. J Med Assoc Thai, 2012, 95(3): 430.
  • 9Patel M, Shariff M I, Ladep N G, et al. Hepatocellular car- cinoma: diagnostics and screening [J]. J Eval Clin Pract, 2012, 18(2): 335.
  • 10石明,陈继安,林小军,陈敏山,郭荣平,李升平,李锦清.肝动脉栓塞化疗不同化疗方案治疗不可切除肝癌的前瞻性随机对照研究[J].中国肿瘤临床,2009,36(1):9-13. 被引量:27

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部